These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 22085320)
41. Muscle symptoms associated with statins: a series of twenty patients. Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891 [TBL] [Abstract][Full Text] [Related]
42. Statin-associated myopathy and its exacerbation with exercise. Meador BM; Huey KA Muscle Nerve; 2010 Oct; 42(4):469-79. PubMed ID: 20878737 [TBL] [Abstract][Full Text] [Related]
43. Statin-associated myopathy with normal creatine kinase levels. Hyman MH Ann Intern Med; 2003 Jun; 138(12):1007; author reply 1008-9. PubMed ID: 12809466 [No Abstract] [Full Text] [Related]
44. [Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge]. Yiğiner O; Ozmen N; Ozçelik F; Inanç T; Kardeşoğlu E; Uz O; Işılak Z; Aparcı M; Sahin I; Arslan E; Cebeci BS Turk Kardiyol Dern Ars; 2010 Dec; 38(8):544-50. PubMed ID: 21248454 [TBL] [Abstract][Full Text] [Related]
45. Creatine kinase: a review of its use in the diagnosis of muscle disease. Gasper MC; Gilchrist JM Med Health R I; 2005 Nov; 88(11):398, 400-4. PubMed ID: 16363394 [No Abstract] [Full Text] [Related]
46. [Enduracin--a nicotinic acid preparation in the treatment of hypercholesterolemia]. Kardiologiia; 1993; 33(11):67-80. PubMed ID: 8145429 [No Abstract] [Full Text] [Related]
47. Statin-associated myopathy with normal creatine kinase levels. Torgovnick J; Arsura E Ann Intern Med; 2003 Jun; 138(12):1007; author reply 1008-9. PubMed ID: 12809467 [No Abstract] [Full Text] [Related]
48. Statin-associated myopathy with normal creatine kinase levels. Toma E; Loignon M Ann Intern Med; 2003 Jun; 138(12):1007-8; author reply 1008-9. PubMed ID: 12809465 [No Abstract] [Full Text] [Related]
49. Reversible myopathy after statin therapy in patients with normal creatine kinase levels. Bennett WE; Drake AJ; Shakir KM Ann Intern Med; 2003 Mar; 138(5):436-7. PubMed ID: 12614104 [No Abstract] [Full Text] [Related]
50. Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia. Shah S; Ceska R; Gil-Extremera B; Paolini JF; Giezek H; Vandormael K; Mao A; McCrary Sisk C; Maccubbin D Int J Clin Pract; 2010 May; 64(6):727-38. PubMed ID: 20518948 [TBL] [Abstract][Full Text] [Related]
51. Influenza vaccine does not produce myopathy in patients taking statins. Chazan B; Weiss R; Tabenkin H; Mines M; Raz R J Fam Pract; 2002 Nov; 51(11):986, 988. PubMed ID: 12485562 [No Abstract] [Full Text] [Related]
52. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease? Ahmed MH J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417 [TBL] [Abstract][Full Text] [Related]
53. Statin-associated myopathy with normal creatine kinase levels. Teichholz LE Ann Intern Med; 2003 Jun; 138(12):1008; author reply 1008-9. PubMed ID: 12809468 [No Abstract] [Full Text] [Related]